Menopur

Menotrophin, the active ingredient in Menopur, is a Gonadotropin (FSH/LH) preparation presented as an injectable solution for intramuscular or subcutaneous use. It provides exogenous FSH and LH activity to stimulate follicular development and ovulation in women undergoing fertility treatment.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and offers reliable cold‑chain logistics for biologic products. Our distribution network ensures timely delivery to reproductive medicine centres across Europe, Asia and the Americas.

Menopur is used in reproductive medicine to support ovarian stimulation and ovulation induction.

- Infertility due to anovulation: stimulates follicular development to promote ovulation in women with anovulatory infertility. - Assisted reproductive technology (ART) stimulation: enhances follicle growth to increase the number of oocytes retrieved for IVF or ICSI cycles. - Controlled ovarian hyperstimulation: provides controlled FSH/LH activity to achieve optimal ovarian response during fertility treatment protocols.

Menopur may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the administration site. - Abdominal bloating: transient abdominal distension following stimulation. - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): potentially severe fluid shift and thromboembolic risk. - Multiple pregnancy: increased likelihood of twins or higher-order gestations. - Allergic reaction: rash, urticaria, or anaphylaxis in rare cases.

When prescribing Menopur, clinicians should observe several precautionary measures to optimise safety and efficacy.

- Monitor ovarian response: use ultrasound and estradiol levels to adjust dosing. - Assess thyroid function: avoid use in uncontrolled thyroid disease. - Evaluate for hypersensitivity: discontinue if allergic signs appear. - Caution with ovarian cysts: consider alternative protocols if cysts are present. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medications, influencing ovarian response or increasing risk of complications.

Major Interactions (Avoid): - GnRH agonist therapy: may amplify ovarian response and raise OHSS risk. - Estrogen‑containing medications: can alter follicular dynamics and reduce efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may suppress endogenous gonadotropins, requiring careful timing. - Thyroid hormone therapy: monitor thyroid status as it can affect ovarian sensitivity. - Corticosteroids: may modify ovarian response and require dose adjustment.